Trademark applications and grants for Hemispherx Biopharma Inc. Hemispherx Biopharma Inc has 1 trademark applications. The latest application filed is for "ALFERON N INJECTION"
Patent Application | Date |
---|---|
METHOD OF REDUCING ANTIGENIC DRIFT OR REASSORTMENT OF VIRUSES IN A HOST ANIMAL USING ALPHA INTERFERON 20160199449 - 14/913562 CARTER; William A. ;   et al. | 2016-07-14 |
DSRNAS AS INFLUENZA VIRUS VACCINE ADJUVANTS OR IMMUNO-STIMULANTS 20150064216 - 14/537981 CARTER; William A. ;   et al. | 2015-03-05 |
NOVEL DOUBLE-STRANDED RIBONUCLEIC ACIDS WITH RUGGED PHYSICO-CHEMICAL STRUCTURE AND HIGHLY SPECIFIC BIOLOGIC ACTIVITY 20140335112 - 14/275754 CARTER; William A. ;   et al. | 2014-11-13 |
Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity 20100160413 - 12/591270 Carter; William A. ;   et al. | 2010-06-24 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
"ALFERON N INJECTION" 1898544 74535420 |
ALFERON N INJECTION 1994-06-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.